Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: The Italian experience

Neurological Sciences

Volumn 30, Issue 3, 2009, Pages 193-199

  Ghezzi, Angelo ^a   Amato, Maria Pia ^b   Annovazzi, Pietro ^a   Capobianco, Marco ^c   Gallo, Paolo ^d   La Mantia, Loredana ^e   Marrosu, Maria Giovanna ^f   Martinelli, Vittorio ^g   Milani, Nicoletta ^e   Moiola, Lucia ^g   Patti, Francesco ^h   Pozzilli, Carlo ⁱ   Trojano, Maria ^j   Zaffaroni, Mauro ^a   Comi, Giancarlo ^e   Simone, I L ^j   Di Monte, Elisabetta ^j   Ardito, R ^k   Stecchi, S ^l   Scandellari, C ^l   Marrosu, M G ^f   Spinicci, G ^f   D'Amico, E ^h   Portaccio, E ^b   Lori, S ^m   Costantino, G F ⁿ   Pilato, V ^a   Zaffaroni, M ^a   Bellantonio, A ^o   Fantozzi, R ^o   Milanese, C ^e   Scarpini, E ^p   De Riz, M ^p   Sola, P ^q   Merelli, E ^q   Guerra, A ^q   Perini, P ^d   Atzori, M ^d   Bergamaschi, R ^r   Veggiottii, P ^r   Prosperini, L ⁱ   Bertolotto, A ^c   Malucchi, S ^c   Cavalla, P ^s   more..

^a Ospedale di Gallarate   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k Section of Allergology and Clinical Immunology   (Italy)

^l Centro Sclerosi Multipla   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ Struttura Semplice Sclerosi Multipla   (Italy)

^o IRCCS NEUROMED   (Italy)

^p UNIVERSITY OF MILAN   (Italy)

^q Clinica Neurologica   (Italy)

^r C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^s UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Adolescence; Childhood; Glatiramer acetate; Immunomodulatory agents; Interferon beta; Multiple sclerosis; Paediatric multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EXPERIENCE; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INJECTION SITE REACTION; ITALY; LIVER FUNCTION TEST; LONG TERM CARE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYALGIA; ONSET AGE; PATIENT COMPLIANCE; RELAPSE; SCORING SYSTEM; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 67349159369     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0083-1     Document Type: Article

References (20)

1. Goodin DS, Frohman EM, Garmany GP et al, the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines (2002) Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169-178
2. Waubant E, Hietpas J, Stewart T et al (2001) Interferon-beta1a in children with multiple sclerosis is well tolerated. Neuropediatrics 32:211-213
3. Mikaeloff Y, Moreau T, Debouverie M et al (2001) Interferon-beta treatment in patients with childhood onset multiple sclerosis. J Pediatr 139:443-446
4. Pohl D, Rostasy K, Gartner J, Hanefeld F (2005) Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 64:888-890
5. Banwell B, Reder AT, Krupp L et al (2006) Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 66:472-476
6. Tenembaum SN, Segura MJ (2006) Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 67:511-513
7. Ghezzi A, Amato MP, Capobianco M et al, the Immunomodulatory Treatment of Early Onset MS Group (2005) Disease modifying drugs in childhood-juvenile multiple sclerosis: Results of an Italian co-operative study. Mult Scler 11:420-424
8. Pakdaman H, Fallah A, Sahraian MA et al (2006) Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a. Neuropediatrics 37:257-260
9. Ghezzi A, on behalf of the Immunomodulatory Treatment of Early Onset MS ITEMS Group (2005) Immunomodulatory treatment of early onset MS: Results of an Italian co-operative study. Neurol Sci 26(suppl 4):S183-S186
10. Ghezzi A, Amato MP, Capobianco M et al (2007) Treatment of early-onset multiple sclerosis with intramuscular Interferon-beta1a: Long term results. Neurol Sci 28:129-134
11. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121-127
12. Lublin F, Reingold SC (1996) Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
13. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
14. Mikaeloff Y, Caridare G, Tardieu M et al (2008) Effectiveness of early interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study. Eur J Paediatr Neurol 12:205-209
15. Kornek B, Bernert G, Balassy C et al (2003) Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 34:120-126
16. Ghezzi A, Pozzilli C, Liguori M et al (2002) Prospective study of multiple sclerosis with early onset. Mult Scler 8:115-118
17. Gusev E, Boiko A, Bikova O et al (2002) The natural history of early onset multiple sclerosis: Comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg 104:203-207
18. Renoux C, Vukusic S, Mikaeloff Y et al (2007) Natural history of multiple sclerosis with childhood onset. N Engl J Med 356:2603-2613
19. Banwell B, Krupp L, Kennedy J et al (2007) Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study. Lancet Neurol 6:773-781
20. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T (2009) Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 66:54-59